ATE306946T1 - Transfektionssystem - Google Patents

Transfektionssystem

Info

Publication number
ATE306946T1
ATE306946T1 AT01934009T AT01934009T ATE306946T1 AT E306946 T1 ATE306946 T1 AT E306946T1 AT 01934009 T AT01934009 T AT 01934009T AT 01934009 T AT01934009 T AT 01934009T AT E306946 T1 ATE306946 T1 AT E306946T1
Authority
AT
Austria
Prior art keywords
transfection
cell suspension
providing
component
components
Prior art date
Application number
AT01934009T
Other languages
English (en)
Inventor
Christoph Andree
Matthias Voigt
G Bjoern Stark
Original Assignee
Universitaetsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaetsklinikum Freiburg filed Critical Universitaetsklinikum Freiburg
Application granted granted Critical
Publication of ATE306946T1 publication Critical patent/ATE306946T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Surgery (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Photolithography (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Gyroscopes (AREA)
AT01934009T 2000-05-24 2001-05-23 Transfektionssystem ATE306946T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10025609A DE10025609A1 (de) 2000-05-24 2000-05-24 Transfektionssystem
PCT/EP2001/005937 WO2001089593A1 (en) 2000-05-24 2001-05-23 Transfection system

Publications (1)

Publication Number Publication Date
ATE306946T1 true ATE306946T1 (de) 2005-11-15

Family

ID=7643316

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01934009T ATE306946T1 (de) 2000-05-24 2001-05-23 Transfektionssystem

Country Status (9)

Country Link
US (1) US20040043007A1 (de)
EP (1) EP1292340B1 (de)
JP (3) JP4951185B2 (de)
AT (1) ATE306946T1 (de)
AU (2) AU2001260328A1 (de)
CA (1) CA2410000C (de)
DE (2) DE10025609A1 (de)
ES (1) ES2252234T3 (de)
WO (1) WO2001089593A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007040252A1 (de) * 2006-09-11 2008-06-12 Gerlach, Jörg, Prof. Dr. Sprühapparat für Zellen und Methode zur Anwendung gesprühter Zellen
US8387282B2 (en) 2010-04-26 2013-03-05 Nike, Inc. Cable tightening system for an article of footwear
DE102011100450B8 (de) 2011-04-27 2013-10-17 Jörg Gerlach Apparat zum Sprühen von Zellen, Herstellung des Apparates, Methode zum Sprühen mit dem Apparat und eine Zellsuspension gesprüht mit dem Apparat
ES2399273B1 (es) * 2011-09-13 2014-01-28 Universidad Politécnica De Valencia Estuco para la conservación y restauración de materiales óseos.
CA3027493C (en) 2016-06-14 2021-04-06 Renovacare Sciences Corp. Modular device for cell spraying
CN112957485A (zh) * 2021-02-22 2021-06-15 上海药明生物技术有限公司 一种基于巴氏灭菌的质粒dna灭菌处理方法、所得灭菌质粒dna及应用
CN119193700A (zh) * 2024-11-15 2024-12-27 华南农业大学 一种鸡原始生殖腺细胞的脂质体转染方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5661132A (en) * 1989-12-14 1997-08-26 Auragen, Inc. Wound healing
WO1993024627A1 (en) * 1992-06-03 1993-12-09 Case Western Reserve University Bandage for continuous application of biologicals
US5962427A (en) * 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
DE19521324C1 (de) * 1995-06-12 1996-10-31 Immuno Ag Gewebeklebstoff und Verwendung desselben als Hämostyptikum
DE19716098A1 (de) * 1997-04-17 1998-10-22 Univ Ludwigs Albert Fibroblasten mit einem Fremdgen enthaltende Zusammensetzung zur Behandlung von Wunden
US20020064517A1 (en) * 1998-04-30 2002-05-30 Stewart A. Cederholm-Williams Fibrin sealant as a transfection/transformation vehicle for gene therapy
NZ528340A (en) * 1998-12-02 2005-07-29 Bristol Myers Squibb Co Spray delivery of cells

Also Published As

Publication number Publication date
DE60114193T2 (de) 2006-11-23
JP2008208145A (ja) 2008-09-11
AU2007201342B2 (en) 2009-01-08
EP1292340A1 (de) 2003-03-19
AU2007201342A1 (en) 2007-04-19
JP2004531453A (ja) 2004-10-14
WO2001089593A1 (en) 2001-11-29
AU2001260328A1 (en) 2001-12-03
CA2410000A1 (en) 2001-11-29
DE60114193D1 (de) 2006-03-02
CA2410000C (en) 2011-01-25
JP4951185B2 (ja) 2012-06-13
DE10025609A1 (de) 2001-12-13
EP1292340B1 (de) 2005-10-19
US20040043007A1 (en) 2004-03-04
ES2252234T3 (es) 2006-05-16
JP2012021034A (ja) 2012-02-02

Similar Documents

Publication Publication Date Title
AR020055A1 (es) Una composicion farmaceutica o cosmetica que contiene una sustancia de esmalte activa, usos de dicha composicion y un metodo para preparar la misma.
DE69534669D1 (de) Nukleinsaeure enthaltende zusammensetzungen, herstellung und verwendung
NO20035569D0 (no) Sårbandasje og metode for kontroll av livstruende bl degree dning
ATE277645T1 (de) Peptid-beschichtete implantate und verfahren zu ihrer herstellung
CN1471412B8 (zh) 用于修复和再生软骨和其它组织的组合物以及该组合物的用途
TR199802421T2 (xx) Doku yenilenmesini d�zenleyen maddeler.
WO2005013885A3 (en) Pharmaceutical compositions and methods for accelerating wound healing
DE60103894D1 (de) Sprühfähige wundversorgungszusammensetzung
WO2005079822A3 (en) Pharmaceutical composition comprising a fibrin matrix and dermal fibroblasts for the treatment of wounds
WO2005044179A8 (en) Formulations containing astragalus extracts and uses thereof
WO2009083544A3 (en) Pdgf fusion proteins incorporated into fibrin foams
BRPI0318278B8 (pt) Compostos de éter aminocicloexílico, composição compreendendo ditos compostos, usos dos mesmos e método para modular a atividade do canal iônico em um ambiente in vitro
ATE445417T1 (de) Ex vivo verfahren und zusammensetzungen zur nukleinsäureverabreichung
DE69902234D1 (de) Matrixprotein enthaltende zusammensetzungen zur wundheilung
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
PT1272199E (pt) Terapias de combinacao com actividade de lesao vascular
DE60114193D1 (de) Transfektionssystem
DE60140191D1 (de) Zusammensetzungen mit matrixproteinen zur regeneration von dentin
DE69510356D1 (de) Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie
DE50009838D1 (de) Humanes antibiotisches protein
DE69920015D1 (de) Verfahren zur induktion der herstellung von wachstumsfaktoren
JP2004531453A5 (de)
WO2003082263A8 (en) Sulfamic acids as inhibitors of human cytoplasmic protein tyrosine phosphatases
DE60115622D1 (de) Methoden und zusammensetzungen zur aufklärung von proteinexpressionsprofilen in zellen
BR0208364A (pt) Novos peptìdeos ligantes das integrinas de leucócitos e uso dos mesmos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1292340

Country of ref document: EP